Perimenopause, hormonal changes, and the science behind symptoms that can begin earlier than many women realize.
She's 34 years old.
She's exhausted despite getting enough sleep. Her periods have become unpredictable. She's noticing more anxiety, occasional night sweats, and changes in her weight that don't seem to make sense.
Her concentration isn't what it used to be.
Her sex drive has changed.
And perhaps most frustrating of all, she doesn't feel like herself anymore.
Eventually, she schedules an appointment, explains everything she's experiencing, and has her hormone levels checked.
The results come back.
"Everything is within normal limits."
But she still doesn't feel normal.
So what happens next?
For many women, this is where the frustration begins.
And it's also where understanding the complicated relationship between hormones, laboratory testing, and individual health becomes especially important.
Women's Hormones Are Anything but Static
Unlike many laboratory measurements, reproductive hormone concentrations change considerably throughout the menstrual cycle.
Estrogen rises and falls. Progesterone increases after ovulation. Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) help coordinate the process.
These hormones work together to regulate menstrual cycles, reproductive function, and numerous physiological processes throughout the body.
Estrogen also influences bone metabolism, reproductive tissues, and temperature regulation, while progesterone plays an essential role in the menstrual cycle and pregnancy.
And these hormonal patterns aren't identical for every woman.
Age, reproductive health, medications, underlying medical conditions, and individual biology can all influence hormone production.
That's why a hormone result requires context.
A number on a laboratory report is information. It isn't the whole story.
Perimenopause Doesn't Always Wait Until Your 50s
When people hear the word menopause, they often picture a woman in her early 50s.
And that makes sense.
Natural menopause generally occurs between ages 45 and 55, with an average age around 51 in the United States.
But menopause and perimenopause aren't the same thing.
Menopause is defined retrospectively after 12 consecutive months without menstruation, when no other cause explains the absence of periods.
Perimenopause is the transition leading up to menopause, during which ovarian hormone production becomes more variable and menstrual patterns may change.
For many women, that transition begins in their 40s.
However, some women begin experiencing menopause-related changes in their late 30s, particularly if ovarian function is declining earlier than expected.
And what about women in their 20s or early 30s?
This is where careful evaluation becomes especially important.
Although typical age-related perimenopause in the late 20s is uncommon, premature ovarian insufficiency can affect women younger than 40, including women in their 20s.
POI is different from ordinary perimenopause. It involves impaired ovarian function before the expected age of menopause, and ovarian activity may be intermittent.
The 2024 international evidence-based guideline on premature ovarian insufficiency emphasizes that POI can affect reproductive health, fertility, bone health, cardiovascular health, and psychological well-being (Panay et al., 2024).
A young woman experiencing symptoms consistent with estrogen deficiency should not automatically be told she's too young for a hormonal problem.
But she also shouldn't automatically be diagnosed with perimenopause.
Her symptoms deserve an appropriate investigation.
The Symptoms Aren't Always What You Expect
Hot flashes are probably the most recognizable symptom associated with menopause.
But reproductive hormonal changes may involve considerably more.
Women may experience:
Changes in menstrual frequency, duration, or flow.
Hot flashes and night sweats.
Sleep disturbances.
Vaginal dryness or discomfort with intercourse.
Changes in sexual desire.
Mood changes and increased irritability.
Difficulty concentrating or subjective brain fog.
Changes in migraine patterns.
Joint discomfort.
Fatigue or reduced overall well-being.
Not everyone experiences the same symptoms.
Some women notice menstrual changes first.
Others become aware of sleep problems or temperature fluctuations before recognizing changes in their cycles.
And symptoms such as fatigue, anxiety, weight gain, and poor concentration aren't specific to hormone deficiency.
They may also occur with thyroid disorders, anemia, depression, sleep disorders, medication effects, or other conditions.
That's why an effective evaluation starts with a conversation about the entire clinical picture.
Normal vs. Optimal: What Do Hormone Numbers Really Mean?
The word normal can be misleading when it's used without explanation.
Laboratory reference ranges represent expected measurements within a particular reference population. They aren't personalized guarantees of physical or emotional well-being.
But there's another side to this conversation.
There is no universally established “optimal” estrogen or progesterone concentration that guarantees every woman will feel her best.
Unlike certain conditions where laboratory levels guide medication dosing, perimenopausal symptoms often cannot be diagnosed or managed effectively by targeting one specific hormone number.
For example, estradiol can fluctuate substantially throughout a menstrual cycle and during the menopausal transition.
A result that appears normal on one day may look different several days later.
The National Institute for Health and Care Excellence (NICE) advises against routinely using estradiol and several other hormone measurements to diagnose perimenopause in otherwise healthy women aged 45 or older.
Instead, diagnosis is generally guided by age, symptoms, and menstrual history.
For women younger than 45, particularly those younger than 40, additional evaluation may be appropriate (NICE, 2026).
This distinction matters.
A woman should not be dismissed simply because her hormone results fall within a printed reference interval.
But neither should an isolated hormone result be used as proof that she requires hormone replacement.
Individualized care means treating clinically significant conditions and symptoms—not chasing laboratory numbers without evidence of benefit.
Why Hormone Testing Still Has an Important Role
If laboratory testing isn't always necessary to diagnose perimenopause, why test hormones at all?
Because the right testing can help answer the right clinical questions.
For example, a woman in her 30s with newly irregular or absent menstrual periods may need evaluation for pregnancy, thyroid dysfunction, elevated prolactin, premature ovarian insufficiency, or other causes.
Depending on her history and symptoms, testing may include FSH, estradiol, thyroid studies, prolactin, or additional investigations.
For suspected POI, the 2024 international guideline uses menstrual disturbance lasting at least four months together with an elevated FSH concentration above 25 IU/L, with repeat testing when diagnostic uncertainty remains (Panay et al., 2024).
The key is that testing should be selected for a clinical reason.
Broad hormone panels marketed as a way to discover everyone's unique “optimal levels” aren't necessarily more accurate or helpful.
Sometimes more laboratory testing simply produces more numbers without providing a clearer diagnosis.
When Hormone Replacement Therapy Can Make a Difference
Hormone replacement therapy, or HRT, is among the most effective treatments available for certain menopause-related symptoms.
The 2022 position statement from The North American Menopause Society identifies systemic menopausal hormone therapy as the most effective treatment for vasomotor symptoms such as hot flashes and night sweats.
Hormone therapy also helps prevent bone loss and fractures in appropriately selected patients.
For most healthy symptomatic women younger than 60 or within 10 years of menopause onset, and without contraindications, the benefit-risk balance is generally favorable for treating bothersome symptoms and preventing bone loss (The North American Menopause Society Advisory Panel, 2022).
But treatment isn't one-size-fits-all.
Options may include systemic estrogen delivered through a patch, gel, spray, or oral preparation.
Women with a uterus generally need an appropriate progestogen alongside systemic estrogen to protect the endometrium.
Women without a uterus may be candidates for estrogen-only treatment.
For vaginal dryness or certain urinary and genital symptoms, local vaginal estrogen may be appropriate without systemic hormone therapy.
Treatment selection depends on symptoms, medical history, reproductive anatomy, individual risk factors, and patient preferences.
Why Early Estrogen Deficiency Matters Beyond Symptoms
One of the most important distinctions in women's hormone health involves premature ovarian insufficiency.
When ovarian function declines substantially before age 40, the consequences can extend beyond hot flashes and menstrual irregularities.
Estrogen plays a role in maintaining bone health, and prolonged estrogen deficiency at a young age can contribute to reduced bone density and fracture risk.
POI is also associated with increased cardiovascular and other long-term health risks.
This is why hormone therapy for POI is approached differently from treatment of ordinary menopausal symptoms in older women.
The 2024 international POI guideline recommends hormone therapy, when not contraindicated, until approximately the usual age of menopause—even for some women without significant estrogen-deficiency symptoms.
The purpose is not simply to improve how someone feels today.
It is also to help reduce risks associated with prolonged premature estrogen deficiency (Panay et al., 2024).
That doesn't mean hormone therapy has been proven to prevent cardiovascular events in every woman.
It means the health consequences of losing ovarian function decades earlier than expected deserve serious consideration.
What About Testosterone for Women?
Testosterone is often associated with men's health, but women naturally produce it, too.
Testosterone contributes to aspects of sexual function and other physiological processes.
However, testosterone therapy in women requires careful consideration.
Evidence supports a potential benefit for appropriately selected postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD).
There is not sufficient evidence to routinely prescribe testosterone to women for general fatigue, weight loss, brain fog, or the nonspecific goal of hormone optimization.
If testosterone therapy is considered, physiological dosing and appropriate monitoring are important to avoid excessive androgen exposure.
Like estrogen and progesterone therapy, testosterone treatment should be based on an appropriate clinical indication—not simply a desire to move a laboratory result toward the upper end of a reference range.
Hormone Therapy Isn't Risk-Free
Although hormone therapy can be beneficial, it isn't appropriate for everyone.
Potential concerns include venous thromboembolism, stroke, certain hormone-sensitive cancers, unexplained vaginal bleeding, and other conditions that may influence treatment decisions.
The risks vary depending on the medication, dose, route of administration, timing, and individual medical history.
For some patients, transdermal estrogen may be preferable to oral estrogen because observational evidence suggests a lower risk of blood clots, although individual decisions still require a careful risk assessment.
And HRT is not contraception.
Women who remain capable of pregnancy may still require birth control, even when experiencing perimenopausal symptoms.
For women who cannot or prefer not to use systemic hormone therapy, evidence-based nonhormonal treatments are also available.
Good hormone care isn't about giving every woman hormones. It's about understanding when treatment is appropriate, what it can realistically accomplish, and when another approach would be safer.
What If You're Only 29, 34, or 38?
If you're younger than the typical age of menopause and experiencing unexplained symptoms, don't assume there must be something wrong with your reproductive hormones.
But don't assume hormonal conditions are impossible, either.
Pay attention to changes in your menstrual cycle.
Consider whether medications, contraception, sleep, stress, or other medical conditions could be influencing your symptoms.
Seek evaluation for persistent irregular periods, absent menstruation, recurrent hot flashes, or other concerns that affect your quality of life.
A thorough assessment may reveal a hormonal condition.
It may identify a different medical problem.
Or it may provide reassurance that a particular symptom isn't caused by hormone deficiency.
All three outcomes have value.
Women's Health Deserves More Than a Reference Range
For too long, conversations about women's hormones have been surrounded by conflicting messages.
Some women are told their symptoms are simply part of aging.
Others are promised that virtually every concern can be corrected through hormone optimization.
Neither extreme reflects the complexity of women's health.
Hormones matter.
Symptoms matter.
Laboratory results matter.
But so do age, medical history, lifestyle, reproductive goals, and individual preferences.
A woman in her 30s who doesn't feel like herself deserves to be heard.
A woman in her 50s struggling with disruptive menopausal symptoms deserves access to evidence-based treatment options.
And a woman with premature ovarian insufficiency deserves appropriate evaluation and counseling about both her immediate symptoms and long-term health.
Because normal on paper doesn't always explain how someone feels.
And feeling different doesn't automatically mean hormones are the cause.
The goal isn't to make every woman's hormone levels look the same.
It's to understand the person behind the numbers, identify what's actually happening, and make informed decisions that support her health.
— Kayla Brewer-Clements, MSN, APRN, FNP-C
References
American College of Obstetricians and Gynecologists. (2025, September). Do I need to have testing of my hormone levels during perimenopause? https://www.acog.org/womens-health/experts-and-stories/ask-acog/do-i-need-to-have-testing-of-my-hormone-levels-during-perimenopause
National Institute for Health and Care Excellence. (2026). Menopause: Identification and management (NICE Guideline NG23). https://www.nice.org.uk/guidance/ng23
Panay, N., Anderson, R. A., Bennie, A., Cedars, M., Davies, M., Ee, C., Gravholt, C. H., Kalantaridou, S., Kallen, A., Kim, K. Q., Misrahi, M., Mousa, A., Nappi, R. E., Rocca, W. A., Ruan, X., Teede, H., Vermeulen, N., Vogt, E., & Vincent, A. J. (2024). Evidence-based guideline: Premature ovarian insufficiency. Human Reproduction Open, 2024(4), Article hoae065. https://doi.org/10.1093/hropen/hoae065
The North American Menopause Society Advisory Panel. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028
Educational disclaimer: This article is intended for general health education and does not constitute individualized medical advice, diagnosis, or treatment. Hormonal symptoms can have many causes. Hormone therapy requires appropriate evaluation, individualized risk assessment, and clinical monitoring.
